Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Benign Hematology
•
Thalassemia
What could explain failure to luspatercept in patients with transfusion-dependent beta thalassemia?
Related Questions
For pregnant nontransfusion dependent beta thalassemia patients, when would you consider ESAs for worsening anemia?
Do you routinely genotype adult beta thalassemia patients?
What unique work up or management would you offer for stroke in patients with sickle cell trait, beyond standard stroke management?
Do you routinely screen and replace Vitamin D in patients with ITP?
What is your experience using sucrosomial iron for symptomatic iron deficient patients who are intolerant of ferrous sulfate and prefer an oral regimen?
Would you consider a positive DAT and indirect Coombs test, persistent and consistent with IgG warm antibody, clinically significant in absence of hemolysis?
How do you manage copper deficiency?
Would you consider prophylactic anticoagulation for May-Thurner syndrome in pregnancy if prior endovascular intervention has been completed?
How often do you check weight and adjust anticoagulation dosing in pregnancy?
Do you routinely use antifibrinolytics for patients with heavy menstrual bleeding who are already on hormonal therapy?
